New drug trial targets rare joint tumor and advanced cancers
NCT ID NCT03069469
Summary
This study is testing an experimental drug called vimseltinib in adults with advanced solid tumors or a rare joint tumor called tenosynovial giant cell tumor (TGCT). The first phase aims to find the safest and most effective dose. The second phase will focus on TGCT patients to see how well the drug shrinks tumors and improves pain and movement.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED MALIGNANT NEOPLASM are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centre Leon Berard
Lyon, France
-
Dana Farber
Boston, Massachusetts, 02215, United States
-
Fondazione IRCCS Istituto Nazionale Dei Tumori
Milan, Italy
-
Gustave Roussy Cancer Campus Grand Paris
Paris, France
-
Hospital Clinico San Carlos
Madrid, Spain
-
Hospital Universitario Vall d'Hebron
Barcelona, Spain
-
Hospital Universitario Virgen del Rocío, Sevilla
Seville, Spain
-
IRCCS Istituto Ortopedico Rizzoli
Bologna, Italy
-
Istituto Nazionale dei Tumori
Milan, Italy
-
Leiden University Medical Center
Leiden, Netherlands
-
M. Sklodowska-Curie Memorial Cancer Center
Warsaw, Poland
-
MSKCC
New York, New York, 10065, United States
-
Mayo Clinic
Jacksonville, Florida, 32224, United States
-
McGill University Health Centre
Montreal, Quebec, Canada
-
OHSU
Portland, Oregon, 97239, United States
-
Oregon Health & Science University
Portland, Oregon, 97239, United States
-
Peter MacCallum Cancer Centre
Melbourne, Australia
-
Princess Margaret Cancer Center
Toronto, Canada
-
Regina Elena National Cancer Institute
Rome, Italy
-
Sarah Cannon Research Institute
Nashville, Tennessee, 37203, United States
-
Stanford Cancer Institute
Palo Alto, California, 94304, United States
-
University College Hospital
London, United Kingdom
-
University of Colorado - Denver
Denver, Colorado, 80204, United States
-
University of Miami
Miami, Florida, 33136, United States
Conditions
Explore the condition pages connected to this study.